Acetris Pharma Holdings, LLC

Rising Pharmaceuticals Inc is a leading provider of generic prescription pharmaceutical products, offering a wide range of therapeutic areas and dosage forms. With state-of-the-art manufacturing facilities, they specialize in producing APIs, intermediates, and challenging dosage forms, including injectables and ophthalmics. Committed to improving lives, Rising Pharmaceuticals aims to make a positive impact on patients, healthcare workers, and the entire supply chain. As an innovative and entrepreneurial company, Rising Pharmaceuticals has recently expanded its sterile dosage capabilities with the opening of a new facility, strengthening the U.S. supply chain. They have also launched important antidote treatments, such as the Edetate Calcium Disodium Injection for addressing lead poisoning. Additionally, Rising Pharmaceuticals actively supports clinical trials, like the Phase 2 trial of Chloroquine Phosphate, to combat COVID-19 and protect healthcare workers at risk. With a focus on integrity, responsibility, service, collaboration, and teamwork, Rising Pharmaceuticals strives to provide high-quality pharmaceutical products that enhance the well-being of individuals and communities.Generated from the website

Fidelis Animal Health, Inc. is a U.S.-based commercial stage company specializing in the acquisition, development, and marketing of unique pharmaceutical formulations to improve animal welfare. With an extensive pipeline and innovative drug delivery technology, they offer high-quality therapeutic solutions that meet specialized veterinary needs. Committed to leading the industry, Fidelis Animal Health has already successfully commercialized one product and continues to develop quality-driven pain management solutions and innovative treatments for laboratory and larger animals using their proprietary extended-release technology.Generated from the website

TG Therapeutics, Inc. is a biopharmaceutical company based in Edison, NJ. They are focused on developing innovative therapies for various diseases, including multiple sclerosis (MS), chronic lymphocytic leukemia (CLL), and marginal zone lymphoma (MZL). Their approved product, BRIUMVI, is indicated for the treatment of relapsing forms of MS in adults. TG Therapeutics is committed to advancing scientific research and collaborating with medical professionals to improve patient outcomes. With a strong leadership team and a robust pipeline of potential therapies, TG Therapeutics is dedicated to making a significant impact in the field of healthcare. They prioritize patient safety and efficacy in their approach to drug development, and their dedication to scientific excellence is evident in their numerous publications and ongoing clinical trials. As a company, TG Therapeutics is driven by a fearless pursuit of innovative solutions and welcomes collaboration with medical professionals and researchers in their mission to improve the lives of patients.Generated from the website